Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

Comment by DrAuditon Jul 09, 2012 8:55am
304 Views
Post# 20093899

RE: RE: FINAL GEA REPORT

RE: RE: FINAL GEA REPORT

Indeed.

What interests me is this.  KPMG had them revalue their assets based on revenue generation - BXI assessed the asset value at 70 mill based on their DCF of projected future revenues.  If GEA qualifies its opinion about the viability of the process, will their be another write-down?  If GEA says "no", does that automatically motivate KP to go back to their "going concern" position and revise it?

 

<< Previous
Bullboard Posts
Next >>